Stock comparison
AbbVie Inc. is 7.7x more valuable than REGENERON PHARMACEUTICALS, INC. by market capitalization ($440.14 B vs $56.80 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ABBV is larger
AbbVie Inc. is 7.7x more valuable than REGENERON PHARMACEUTICALS, INC. by market capitalization ($440.14 B vs $56.80 B).
Market value leader
ABBV
AbbVie Inc. is 7.7x more valuable than REGENERON PHARMACEUTICALS, INC. by market capitalization ($440.14 B vs $56.80 B).
Revenue leader
ABBV
REGN: $14.34B vs ABBV: $61.16B.
Profit leader
REGN
REGN: $4.50B vs ABBV: $4.23B.
Margin leader
REGN
REGN: 31.4% vs ABBV: 6.9% net margin.
| Metric | REGN | ABBV |
|---|---|---|
| Market cap | $56.80 B | $440.14 B |
| US-listed rank | #291 | #25 |
| Revenue (latest FY) | $14.34B | $61.16B |
| Net income (latest FY) | $4.50B | $4.23B |
| Net margin | 31.4% | 6.9% |
| P/E (trailing FY) | 12.6x | 104.2x |
| SEC filings | 985 | 1,008 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AbbVie Inc. is 7.7x more valuable than REGENERON PHARMACEUTICALS, INC. by market capitalization ($440.14 B vs $56.80 B).
In their latest fiscal years, REGENERON PHARMACEUTICALS, INC. reported $14.34B in revenue while AbbVie Inc. reported $61.16B.
Full pages: REGENERON PHARMACEUTICALS, INC. and AbbVie Inc., or browse the full rankings.